Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v30-FR Version v29-EN
Language French English
Date Updated 2018-08-09 2018-08-09
Drug Identification Number 02431130 02431130
Brand name VINORELBINE INJECTION, USP VINORELBINE INJECTION, USP
Common or Proper name 10 mg/ml Vinorelbine (as vinorelbine tartrate) 10 mg/ml Vinorelbine (as vinorelbine tartrate)
Company Name GENERIC MEDICAL PARTNERS INC GENERIC MEDICAL PARTNERS INC
Ingredients VINORELBINE VINORELBINE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ml in clear glass vial 5ml in clear glass vial
ATC code L01CA L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-06 2017-12-06
Estimated end date
Actual end date 2018-08-01 2018-08-01
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments New batches of 5 ml and 1 ml have been manufactured. Contracted 5 ml demand is now being supplied on allocation. Stock levels are being increased with the manufacture of further batches of both vial sizes. New batches of 5 ml and 1 ml have been manufactured. Contracted 5 ml demand is now being supplied on allocation. Stock levels are being increased with the manufacture of further batches of both vial sizes.
Health Canada comments